2024-11-13T13:29:37-06:00 2023-12-31 521711839 COUNCILOR BUCHANAN & MITCHELL PC 7910 WOODMONT AVE STE 500 BETHESDA MD 20814 990 2023-01-01 586032060 AMERICAN SOCIETY FOR PHARMACOLOGY & EXPERIMENTAL THERAPEUTICS AMER 3016347065 1801 ROCKVILLE PIKE 210 ROCKVILLE MD 20852 DAVID JACKSON EXECUTIVE OFFICER 3016347060 2024-11-08 1 1 REEMA A PATEL P01595848 3019860600 2024-11-08 2023 2024-10-15 13:58:12Z DAVID JACKSON 1801 ROCKVILLE PIKE 210 ROCKVILLE MD 20852 11050330 0 X WWW.ASPET.ORG X 1933 MD THE AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (ASPET) IS A 4,000 MEMBER SCIENTIFIC SOCIETY WHOSE MEMBERS CONDUCT BASIC AND CLINICAL PHARMACOLOGICAL RESEARCH AND WORK FOR ACADEMIA, GOVERNMENT, LARGE PHARMACEUTICAL COMPANIES, SMALL BIOTECH COMPANIES, AND NON-PROFIT ORGANIZATIONS. 9 8 22 100 -1330 13788 11810 10917 3828616 4259079 571075 1405014 51773 37363 4463274 5712373 144000 369000 0 0 2335626 3186162 0 0 0 2634893 3589043 5114519 7144205 -651245 -1431832 29344018 30249773 3506639 3630822 25837379 26618951 X THE AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (ASPET) IS A 4,000 MEMBER SCIENTIFIC SOCIETY WHOSE MEMBERS CONDUCT BASIC AND CLINICAL PHARMACOLOGICAL RESEARCH AND WORK FOR ACADEMIA, GOVERNMENT, LARGE PHARMACEUTICAL COMPANIES, SMALL BIOTECH COMPANIES, AND NON-PROFIT ORGANIZATIONS. 0 0 2037723 0 3487135 PUBLICATIONS - THE SOCIETY PUBLISHES SCIENTIFIC AND EDUCATIONAL JOURNALS AND OTHER PUBLICATIONS FOR THE SCIENTIFIC COMMUNITY INCLUDING THE FOLLOWING:JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS - MONTHLY RESEARCH PUBLICATION COVERING TOPICS INCLUDING THE INTERACTIONS OF CHEMICALS WITH BIOLOGICAL SYSTEMS, INCLUDING AUTONOMIC, BEHAVIORAL, CARDIOVASCULAR, CELLULAR, CLINICAL, DEVELOPMENTAL, GASTROINTESTINAL, IMMUNO-, NEURO-, PULMONARY AND RENAL PHARMACOLOGY, AS WELL AS ANALGESICS, DRUG ABUSE, METABOLISM AND DISPOSITION, CHEMOTHERAPY, AND TOXICOLOGY.PHARMACOLOGICAL REVIEWS - QUARTERLY REVIEW JOURNAL COVERING CONCENTRATIONS IN PHARMACOLOGY, EXPERIMENTAL THERAPEUTICS, TOXICOLOGY, AND CHEMOTHERAPY.MOLECULAR PHARMACOLOGY - MONTHLY PUBLICATION WITH AN EMPHASIS ON RESEARCH OF DRUG ACTION AND SELECTIVE TOXICITY AT THE MOLECULAR LEVEL. ORIGINAL APPLICATIONS OF BIOCHEMISTRY, BIOPHYSICS, GENETICS AND MOLECULAR BIOLOGY ARE COMBINED WITH PHARMACOLOGIC RESEARCH TO SOLVE BASIC PROBLEMS IN PHARMACOLOGY AND TOXICOLOGY.DRUG METABOLISM AND DISPOSITION - MONTHLY PUBLICATION COVERING THE FIELDS OF PHARMACOKINETICS, PHARMACODYNAMICS AND MECHANISMS, GENETIC NUTRITIONAL OR HORMONAL FACTORS AFFECTING THE BIOLOGICAL FATE OF CHEMICALS, AND THE TOXICOLOGICAL CONSEQUENCES OF XENOBIOTIC METABOLISM.THE PHARMACOLOGIST - QUARTERLY PUBLICATION WITH THE PURPOSE OF INFORMING PHARMACOLOGISTS ABOUT SOCIETY AFFAIRS AND OTHER MATTERS OF PROFESSIONAL INTEREST. DISTRIBUTED ELECTRONICALLY TO ASPET MEMBERS AND MAILED TO NONMEMBER SUBSCRIBERS AS WELL AS MEMBERS WHO PAY FOR A PRINT SUBSCRIPTION. 1224620 0 422767 MEETINGS - THE SOCIETY HOSTS AN ANNUAL MEETING EACH YEAR IN A DIFFERENT PART OF THE US PROVIDING A FORUM FOR SCIENTISTS TO COMMUNICATE AND EXCHANGE PHARMACOLOGICAL KNOWLEDGE THROUGH SCIENTIFIC SESSIONS. SMALLER FOCUSED MEETINGS ARE HELD ON AN OCCASIONAL BASIS AS THE NEED ARISES. 770910 369000 0 AWARDS - THE SOCIETY OFFERS THREE TYPES OF AWARDS TO DISTINGUISHED PHARMACOLOGISTS AND TO STUDENTS AND YOUNG SCIENTISTS IN THE FIELD. SCIENTIFIC AWARDS ARE PROVIDED TO RECOGNIZE AND ENCOURAGE OUTSTANDING RESEARCH BY PROMINENT PHARMACOLOGISTS AND TO STIMULATE FUNDAMENTAL RESEARCH BY YOUNG INVESTIGATORS. BEST POSTER AWARDS ARE PRESENTED TO MEETING ATTENDEES WHO HAVE SUBMITTED AN OUTSTANDING RESEARCH ABSTRACT FOR PRESENTATION AT THE MEETING. TRAVEL AWARDS ARE GRANTED TO STUDENTS AS AN EDUCATIONAL TOOL TO ATTEND SCIENTIFIC MEETINGS. 582383 0 0 MARKETING - TO PROMOTE ASPET'S PROGRAMS AND SERVICES, PRODUCE THE PHARMACOLOGIST, ASPET'S MONTHLY NEWSLETTER, PROMOTE MEMBERSHIPS AND THE ANNUAL MEETING. 512660 0 349177 MEMBER SERVICES - INCLUDES MEMBERSHIP COMMUNICATIONS AND DIVISIONS TO ADDRESS SPECIFIC AREAS OF CONCERN OR INTEREST TO THE MEMBER PHARMACOLOGISTS IN THE SOCIETY. NOMINATION AND ELECTION OF NEW MEMBERS, DEVELOPMENT OF EDUCATIONAL ACTIVITIES RELEVANT TO THE PROMOTION AND ADVANCEMENT OF THE SCIENTIFIC DISCIPLINE. WEB SITE PROVIDES AN INTERFACE BETWEEN MEMBERS AND THE SOCIETY AS WELL AS INFORMATION TO INDIVIDUALS WISHING TO LEARN MORE ABOUT THE FIELD OF PHARMACOLOGY. 206460 0 0 EDUCATIONAL AFFAIRS - SUPPORTS SUMMER UNDERGRADUATE RESEARCH FELLOWSHIPS IN THE FIELD OF PHARMACOLOGY. 185403 0 0 PUBLIC SERVICES - PROVIDES INFORMATION TO THE GENERAL PUBLIC ABOUT PHARMACOLOGY AND SCIENTIFIC ACHIEVEMENTS AND NEEDS IN THE FIELD. OFFICERS AND MEMBERS PROVIDE A RESOURCE TO THE COMMUNITY WHEN THERE IS A NEED FOR SPECIALIZED EXPERTISE. THE EDUCATION DIVISION CONDUCTS SPECIAL SESSIONS DEVOTED TO IMPROVING EDUCATION IN THE PHARMACOLOGICAL SCIENCES. 1486906 0 349177 5520159 1 0 0 0 0 0 0 0 1 1 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 37 0 1 22 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 9 8 0 0 0 0 1 1 1 1 1 0 1 0 1 1 1 1 1 1 1 1 0 MD VA X THE ORGANIZATION 3016347060 1801 ROCKVILLE PIKE 210 ROCKVILLE MD 20852 XINXIN DING SEC/TREAS ELECT, THEN SEC/TREAS 5.00 X X 35000 0 0 MICHAEL L JARVIS PRESIDENT, THEN PAST PRESIDENT 5.00 X X 0 0 0 NAMANDJE BUMPUS PRESIDENT ELECT, THEN PRESIDENT 5.00 X X 0 0 0 MARGARET GNEGY PAST PREDIDENT 5.00 X X 0 0 0 KATHRYN CUNNINGHAM SEC/TREAS, THEN PAST SEC/TREAS 5.00 X X 0 0 0 CAROL BECK PAST SEC/TREAS, THEN PRES ELECT 5.00 X X 0 0 0 PAM HORNBY SEC/TREAS ELECT 5.00 X X 0 0 0 RANDY HALL COUNCILOR 5.00 X 0 0 0 JOHN TRAYNOR COUNCILOR 5.00 X 0 0 0 NINA ISOHERRANEN COUNCILOR 5.00 X 0 0 0 DAVID JACKSON EXECUTIVE OFFICER 40.00 X 305502 0 10959 ROBERT STANLEY CHIEF FINANCIAL OFFICER 40.00 X 203566 0 40419 MELISSA HUSTON MEETINGS DIRECTOR 40.00 X 150741 0 28675 MARIA PASHO JOURNAL DIRECTOR 40.00 X 161777 0 22365 LYNNE HARRIS MARKETING DIRECTOR 40.00 X 152835 0 15170 CATHERINE FRY EDUCATION DIRECTOR 40.00 X 152636 0 33727 CARTER ALLEMAN GOVT AFFAIRS & SCIENCE POL DIRECTOR 40.00 X 146577 0 5103 1308634 0 156418 9 0 1 0 FASEB 6120 EXECUTIVE BLVD STE 230 ROCKVILLE MD 20852 BENEFITS & HR SERVICES 857499 ST LOUIS-UNION STATION HOTEL 1820 MARKET ST ST LOUIS MO 63103 HOSTING SITE FOR ANNUAL MEETING 558755 KNOWLEDGEWORKS GLOBAL LTD PO BOX 74007142 CHICAGO IL 60674 SERVICES FOR JOURNAL PRODUCTION 346197 MPS NORTH AMERICA 5728 MAJOR BLVD STE 528 ORLANDO FL 32819 ONLINE PEER REVIEW & JOURNALS 295864 4 10917 10917 PUBLICATIONS 513120 3487135 3488465 -1330 SOCIETY MEETINGS 900099 422767 422767 MEMBER DUES 900099 349177 349177 4259079 642853 642853 6100118 5337957 762161 762161 762161 MISCELLANEOUS 900099 37363 37363 37363 5712373 4297772 -1330 1405014 X 369000 369000 560446 456053 104393 2010688 1636160 374528 209646 170595 39051 232944 189555 43389 172438 140318 32120 6174 2358 3816 45235 17275 27960 164939 164939 1276220 913066 363154 66400 66400 134660 100678 33982 223762 127553 96209 208376 89164 119212 348628 316907 31721 673427 643170 30257 168 168 49322 21538 27784 43535 5400 38135 DUES & SUBSCRIPTIONS 145372 67055 78317 HONORARIA & AWARDS 118373 118373 MISCELLANEOUS 84452 69541 14911 7144205 5520159 1624046 0 1088371 1061544 52953 52953 40241 83508 172396 196772 867825 618791 284721 249034 26613179 27673092 1092157 932870 29344018 30249773 306184 546225 1589880 1684716 52991 57001 1557584 1342880 3506639 3630822 X 23551162 24488897 2286217 2130054 25837379 26618951 29344018 30249773 -1431832 2213404 0 X X 0 1 X 1 0 X 68690 36214 394918 11810 10917 522549 4341366 3970176 3923669 3809481 4260409 20305101 4410056 4006390 4318587 3821291 4271326 20827650 5325 3800 2725 2700 3600 18150 0 5325 3800 2725 2700 3600 18150 20809500 512115 502804 513143 556591 642853 2727506 512115 502804 513143 556591 642853 2727506 34209 18763 18473 12070 -1330 82185 5729 3674 11088 51773 37363 109627 4962109 4531631 4861291 4441725 4950212 23746968 0.87630 0.88170 0.11490 0.10940 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: MISCELLANEOUS - 2019 AMOUNT: $ 5,729. 2020 AMOUNT: $ 3,674. 2021 AMOUNT: $ 11,088. 2022 AMOUNT: $ 51,773. 2023 AMOUNT: $ 37,363. 0 1 X 1353759 1265 170884 112087 1413821 1633028 -204363 74906 1353759 1573400 235683 176055 1633028 1576460 173242 176302 1573400 1390936 268846 83322 1576460 0.98315 0.01685 0 0 867825 618791 249034 249034 OPERATING LEASE LIABILITY 1332088 FINANCE LEASE LIABILITY 10792 1342880 X 7760838 2213404 2213404 5547434 164939 164939 5712373 6979266 0 6979266 164939 164939 7144205 PART IV, LINE 2B: THE SOCIETY ACTS IN A CUSTODIAL CAPACITY FOR IUPHAR SECTION ON DRUG METABOLISM (THE SECTION) AND AMSPC. THE SOCIETY RECEIVES FUNDS AND PAYS APPROVED EXPENSES ON BEHALF OF THE SECTION AND AMSPC. PART V, LINE 4: ORGANIZATION'S ENDOWMENT FUNDS ARE BROKEN INTO TEMPORARILY AND PERMANENTLY RESTRICTED NET ASSETS. TEMPORARILY RESTRICTED FUNDS ARE TO BE USED FOR ORGANIZATIONAL USE. PERMANENTLY RESTRICTED FUNDS ARE INTENDED TO REMAIN AND GENERATE INCOME FOR USES SPECIFIED BY THE DONOR, PRINCIPALLY FOR FELLOWSHIPS. PART X, LINE 2: THE SOCIETY IS EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND APPLICABLE STATE LAW. THE ACCOUNTING STANDARD ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES ADDRESSES THE DETERMINATION OF WHETHER TAX BENEFITS CLAIMED OR EXPECTED TO BE CLAIMED ON A TAX RETURN SHOULD BE RECORDED IN THE FINANCIAL STATEMENTS. UNDER THAT GUIDANCE, THE SOCIETY MAY RECOGNIZE THE TAX BENEFIT FROM AN UNCERTAIN TAX POSITION ONLY IF IT IS MORE LIKELY THAN NOT THAT THE TAX POSITION WILL BE SUSTAINED ON EXAMINATION BY TAXING AUTHORITIES BASED ON THE TECHNICAL MERITS OF THE POSITION. EXAMPLES OF TAX POSITIONS INCLUDE THE TAX-EXEMPT STATUS OF THE SOCIETY AND VARIOUS POSITIONS RELATED TO THE POTENTIAL SOURCES OF UNRELATED BUSINESS TAXABLE INCOME (UBTI). THE TAX BENEFITS RECOGNIZED IN THE FINANCIAL STATEMENTS FROM SUCH A POSITION ARE MEASURED BASED ON THE LARGEST BENEFIT THAT HAS A GREATER THAN 50% LIKELIHOOD OF BEING REALIZED UPON ULTIMATE SETTLEMENT. THERE WERE NO UNRECOGNIZED TAX BENEFITS IDENTIFIED OR RECORDED AS LIABILITIES FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022. THE SOCIETY'S POLICY WOULD BE TO RECOGNIZE INTEREST AND PENALTIES, IF ANY, ON TAX POSITIONS RELATED TO ITS UNRECOGNIZED TAX BENEFITS IN INCOME TAX EXPENSE IN THE FINANCIAL STATEMENTS. NO INTEREST AND PENALTIES WERE ASSESSED OR RECORDED DURING CALENDAR YEARS ENDED DECEMBER 31, 2023 AND 2022. THE SOCIETY'S FORMS 990, RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX, ARE SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE, GENERALLY FOR THREE YEARS AFTER THEY WERE FILED. 1 CASE WESTERN RESERVE UNIVERSITY 2109 ADELBERT RD WOOD BLDG W151C CLEVELAND OH 44106 341018992 501(C)(3) 0 27000 INSTITUTIONAL SURF AWARD DUKE UNIVERSITY PO BOX 602651 CHARLOTTE NC 28260 560532129 501(C)(3) 0 18000 INSTITUTIONAL SURF AWARD LSU HEALTH SHREVEPORT RM 1-214 PO BOX 33932 SHREVEPORT CA 71130 720702002 501(C)(3) 0 9000 INSTITUTIONAL SURF AWARD MICHIGAN STATE UNIVERSITY B346 LIFE SCIENCES BLDG EAST LANSING MI 48824 386005984 501(C)(3) 0 18000 INSTITUTIONAL SURF AWARD RUTGERS UNIVERSITY 170 FRELINGHUYSEN RD EOHSI 426 PISCATAWAY NJ 08854 226001086 501(C)(3) 0 27000 INSTITUTIONAL SURF AWARD THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 809 S MARSHFIELD AVE M/C 551 CHICAGO IL 60612 376000511 501(C)(3) 0 18000 INSTITUTIONAL SURF AWARD THE RESEARCH FOUNDATION OF SUNY 520 LEE ENTRANCE STE 211 AMHERST NY 14228 141368361 501(C)(3) 0 27000 INSTITUTIONAL SURF AWARD THE UNIVERSITY OF FLORIDA BOARD OF TRUSTEES PO BOX 115500 GAINESVILLE FL 32611 596002052 501(C)(3) 0 27000 INSTITUTIONAL SURF AWARD THE UNIVERSITY OF MICHIGAN MEDICAL SCHOOL 2301 MEDICAL SCIENCE RESEARCH BUILDING III ANN ARBOR MI 48109 386006309 501(C)(3) 0 18000 INSTITUTIONAL SURF AWARD UNIVERSITY OF ARIZONA 1303 E UNIVERSITY BLVD PO BOX 3 TUSCON AZ 85719 742652689 501(C)(3) 0 27000 INSTITUTIONAL SURF AWARD UNIVERSITY OF CINCINNATI PO BOX 932641 CLEVELAND OH 44193 316000989 501(C)(3) 0 27000 INSTITUTIONAL SURF AWARD UNIVERSITY OF NORTH DAKOTA 264 CENTENNIAL DR STOP 7306 GRAND FORKS ND 58202 456002491 501(C)(3) 0 27000 INSTITUTIONAL SURF AWARD UNIVERSITY OF PITTSBURGH PO BOX 371220 PITTSBURGH PA 15251 250965591 501(C)(3) 0 18000 INSTITUTIONAL SURF AWARD UTHSCSA 7703 FLOYD CURL DR MC 7828 SAN ANOTNIO TX 78229 741586031 501(C)(3) 0 9000 INSTITUTIONAL SURF AWARD WASHINGTON STATE UNIVERSITY 412 E SPOKANE FALLS BLVD SPOKANE WA 99202 916001108 501(C)(3) 0 9000 INSTITUTIONAL SURF AWARD PACIFIC UNIVERSITY 2043 COLLEGE WAY FOREST GROVE OR 97116 930386892 501(C)(3) 0 9000 INSTITUTIONAL SURF AWARD UNIVERSITY OF CALIFORNIA AT SAN DIEGO 9500 GILMAN DR LA JOLLA CA 92093 956006144 501(C)(3) 0 9000 INSTITUTIONAL SURF AWARD UNIVERSITY OF NORTH CAROLINA 104 AIRPORT DR CHAPEL HILL NC 27599 566001393 501(C)(3) 0 27000 INSTITUTIONAL SURF AWARD UNIVERSITY OF VIRGINIA 1001 NORTH EMMET ST CHARLOTTESVILLE VA 22904 546001796 501(C)(3) 0 18000 INSTITUTIONAL SURF AWARD 19 PART I, LINE 2: THE SOCIETY OFFERS AWARDS TO DISTINGUISHED PHARMACOLOGISTS AND TO STUDENTS AND YOUNG SCIENTISTS IN THE FIELD. SCIENTIFIC AWARDS ARE PROVIDED TO RECOGNIZE AND ENCOURAGE OUTSTANDING RESEARCH BY PROMINENT PHARMACOLOGISTS AND TO STIMULATE FUNDAMENTAL RESEARCH BY YOUNG INVESTIGATORS. BEST POSTER AWARDS ARE PRESENTED TO MEETING ATTENDEES WHO HAVE SUBMITTED AN OUTSTANDING RESEARCH ABSTRACT FOR PRESENTATION AT THE MEETING. TRAVEL AWARDS ARE GRANTED TO STUDENTS AS AN EDUCATIONAL TOOL TO ATTEND SCIENTIFIC MEETINGS. X X X X 0 0 0 0 0 0 0 0 0 DAVID JACKSON EXECUTIVE OFFICER 305502 0 0 0 0 0 9095 0 1864 0 316461 0 0 0 ROBERT STANLEY CHIEF FINANCIAL OFFICER 203566 0 0 0 0 0 9551 0 30868 0 243985 0 0 0 CATHERINE FRY EDUCATION DIRECTOR 152636 0 0 0 0 0 20652 0 13075 0 186363 0 0 0 MARIA PASHO JOURNAL DIRECTOR 161777 0 0 0 0 0 8701 0 13664 0 184142 0 0 0 MELISSA HUSTON MEETINGS DIRECTOR 150741 0 0 0 0 0 3833 0 24842 0 179416 0 0 0 LYNNE HARRIS MARKETING DIRECTOR 152835 0 0 0 0 0 11050 0 4120 0 168005 0 0 0 CARTER ALLEMAN GOVT AFFAIRS & SCIENCE POL DIRECTOR 146577 0 0 0 0 0 3716 0 1387 0 151680 0 0 0 FORM 990, PART VI, SECTION A, LINE 6 MEMBERSHIP CONSISTS OF REGULAR MEMBERS, RETIRED MEMBERS, AFFILIATE MEMBERS, POSTDOCTORAL, AND STUDENT MEMBERS. FORM 990, PART VI, SECTION A, LINE 7A THE BOARD IS ELECTED FROM A SLATE BY ALL ELIGIBLE MEMBERS. BOARD MEMBERS ARE ALSO MEMBERS OF THE SOCIETY AND THEREFORE, CAN VOTE IN THE ELECTION THAT ELECTS THEM. FORM 990, PART VI, SECTION A, LINE 7B CHANGES TO THE BY-LAWS ARE SUBJECT TO APPROVAL BY THE MEMBERSHIP. FORM 990, PART VI, SECTION B, LINE 10B WHILE THE SOCIETY DOES NOT DIRECTLY GOVERN THE CHAPTER ACTIVITIES, IT DOES PROVIDE PROCEDURAL GUIDELINES TO THE CHAPTERS AND HAS OTHER STEPS IN PLACE TO EVALUATE THAT THE CHAPTERS ACTIVITIES ARE CONSISTENT WITH THE SOCIETY'S TAX-EXEMPT PURPOSES. SUCH AS, BUT NOT LIMITED TO: INTERESTED CHAPTER GROUPS MUST SUBMIT A PETITION TO THE SOCIETY'S EXECUTIVE OFFICER FOR APPROVAL; CHAPTERS MUST SUBMIT ANNUAL REPORTS TO THE EXECUTIVE OFFICER.; THE PRESIDENT OF THE CHAPTER MUST ALSO BE A REGULAR MEMBER OF THE SOCIETY. FORM 990, PART VI, SECTION B, LINE 11B THE EXECUTIVE OFFICER REVIEWED THE RETURN AND FORWARDED COPIES TO COUNCIL MEMBERS PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C EACH MEMBER OF THE COUNCIL ANNUALLY FILLS OUT THE CONFLICT OF INTEREST QUESTIONNAIRE. THE CHAIR ASKS THE COUNCIL AT THE START OF EACH MEETING IF THERE ARE ANY CONFLICTS. IF SO, THE PERSON IN CONFLICT IS ASKED TO RECUSE THEMSELVES FOR THE DISCUSSION. FORM 990, PART VI, SECTION B, LINE 15 IN 2022, THE SOCIETY CONDUCTED A PROCESS IN CONCERT WITH AN OUTSIDE HR CONSULTANT TO UPDATE JOB DESCRIPTIONS AND USE AT LEAST TWO INDEPENDENT COMPENSATION STUDIES FOR SIMILAR POSITIONS IN THE WASHINGTON METROPOLITAN AREA TO ARRIVE AT AT A COMPETITIVE SALARY FOR EACH OF THE SOCIETY'S STAFF POSITIONS. THE SOCIETY THEN WENT THROUGH A SALARY ADJUSTMENT PROCESS FOR STARTING SALARIES BEGINNING IN 2023, FORM 990, PART VI, SECTION C, LINE 19 THE FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G PUBLICATIONS AND COMMISSIONS AND CONSULTING: PROGRAM SERVICE EXPENSES 741,858. MANAGEMENT AND GENERAL EXPENSES 86,041. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 827,899. CONTRACTED SERVICES: PROGRAM SERVICE EXPENSES 171,208. MANAGEMENT AND GENERAL EXPENSES 277,113. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 448,321. FORM 990, PART XII, LINE 2C: THE OVERSIGHT PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR. THE FINANCE COMMITTEE REVIEWS AND APPROVES THE DRAFT AUDIT REPORT.